STRS Ohio’s Precision BioSciences DTIL Stock Holding History

STRS Ohio’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,087	Closed	-$285K	–	2106
2022 Q1	$285K	Buy	3,087 +2,130	+223%	+$289K	﹤0.01%	1614
2021 Q4	$212K	Hold	957	–	–	﹤0.01%	1717
2021 Q3	$331K	Buy	957 +40	+4%	+$13.6K	﹤0.01%	1637
2021 Q2	$344K	Buy	917 +87	+10%	+$26.1K	﹤0.01%	1675
2021 Q1	$257K	Hold	830	–	–	﹤0.01%	1753
2020 Q4	$207K	Buy	830 +57	+7%	+$14K	﹤0.01%	1731
2020 Q3	$142K	Buy	773 +666	+622%	+$132K	﹤0.01%	1747
2020 Q2	$26K	Buy	107 +87	+435%	+$19.1K	﹤0.01%	2013
2020 Q1	$3K	Sell	20 -60	-75%	-$15.7K	﹤0.01%	1989
2019 Q4	$33K	Hold	80	–	–	﹤0.01%	1944
2019 Q3	$20K	Hold	80	–	–	﹤0.01%	1976
2019 Q2	$31K	Buy	+80	New	+$32.2K	﹤0.01%	1983

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

STRS Ohio's DTIL Position: Q2 2022 in Review

STRS Ohio sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 3,087 shares — an estimated $285K sold.

STRS Ohio first reported a position in DTIL in Q2 2019 and held it in 12 quarters. The position peaked at $344K in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

STRS Ohio reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 3,087 Precision BioSciences shares in Q2 2022, an estimated $285K.
STRS Ohio first reported a position in Precision BioSciences in Q2 2019 and held it in 12 quarters.
STRS Ohio's Precision BioSciences position peaked at $344K in Q2 2021.
119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.